Incannex Healthcare (IXHL) Current Assets (2020 - 2026)
Incannex Healthcare (IXHL) posted Current Assets of $80.1 million for Q1 2026, up 7.25% sequentially from $74.7 million in Q4 2025, and up 412.48% YoY from $15.6 million in Q1 2025.
Incannex Healthcare (IXHL) Current Assets (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Current Assets for 7 years, with the latest figure at $80.1 million in Q1 2026.
- Quarterly Current Assets rose 412.48% year-over-year to $80.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.1 million (up 412.48% YoY) and the FY2025 annual result came in at $20.0 million, up 23.21% from the prior year.
- Current Assets improved to $80.1 million in Q1 2026 per IXHL's latest filing, from $74.7 million in the prior quarter.
- Over five years, Current Assets peaked at $80.1 million in Q1 2026 and troughed at $10.5 million in Q4 2024.
- A 5-year average of $34.7 million and a median of $21.3 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 50.76% in 2024, then jumped 610.95% in 2025.
- Over 5 years, Current Assets stood at $42.1 million in 2022, then sank by 49.37% to $21.3 million in 2023, then tumbled by 50.76% to $10.5 million in 2024, then surged by 610.95% to $74.7 million in 2025, then increased by 7.25% to $80.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $80.1 million, $74.7 million, and $78.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Incannex Healthcare | 41.61 Mn | 41.61 Mn | - | 80.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.10 Mn |
| Dec 31, 2025 | 74.68 Mn |
| Sep 30, 2025 | 78.30 Mn |
| Jun 30, 2025 | 19.96 Mn |
| Mar 31, 2025 | 15.63 Mn |
| Dec 31, 2024 | 10.50 Mn |
| Sep 30, 2024 | 15.21 Mn |
| Jun 30, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.32 Mn |
| Dec 31, 2023 | 21.33 Mn |
| Jun 30, 2023 | 23.00 Mn |
| Dec 31, 2022 | 42.13 Mn |
| Jun 30, 2022 | 37.88 Mn |
| Jun 30, 2021 | 9.33 Mn |
| Jun 30, 2020 | 4.24 Mn |